• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性丙型肝炎感染后的自发病毒清除:纵向研究的系统评价

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.

作者信息

Micallef J M, Kaldor J M, Dore G J

机构信息

National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Darlinghurst, Sydney, NSW, Australia.

出版信息

J Viral Hepat. 2006 Jan;13(1):34-41. doi: 10.1111/j.1365-2893.2005.00651.x.

DOI:10.1111/j.1365-2893.2005.00651.x
PMID:16364080
Abstract

A large number of studies have reported on spontaneous viral clearance rates in acute hepatitis C infection, however most have been small, and reported rates have varied quite widely. To improve the precision of the estimated rate of spontaneous viral clearance, a systematic review was conducted of longitudinal studies. Factors associated with viral clearance were also examined. Inclusion criteria for studies were: longitudinal assessment from time of acute hepatitis C; hepatitis C virus RNA analysis as determinant of viral clearance; untreated for acute hepatitis C. Information on study population, and factors that may influence viral clearance were extracted from each study. Viral clearance was defined among individuals with at least 6 months follow-up following acute hepatitis C. The number of subjects with viral clearance was expressed as a proportion for each study and a weighted mean for proportion was calculated. A total of 31 studies were examined. Study populations included nine studies of post-transfusion hepatitis, 19 of acute clinical hepatitis, and three of sero-incident cases. In total, data was available for 675 subjects and the mean study population was 22 (range 4-67). The proportion with viral clearance ranged from 0.0 to 0.8, with a weighted mean of 0.26 (95% CI 0.22-0.29). Factors associated with viral clearance were female gender and acute clinical hepatitis C study population. Further studies are required to more clearly define predictors of clearance and guide therapeutic intervention strategies.

摘要

大量研究报告了急性丙型肝炎感染的病毒自发清除率,然而大多数研究规模较小,报告的清除率差异也很大。为提高病毒自发清除率估计的准确性,对纵向研究进行了系统评价。还研究了与病毒清除相关的因素。纳入研究的标准为:自急性丙型肝炎起进行纵向评估;以丙型肝炎病毒RNA分析作为病毒清除的决定因素;未接受急性丙型肝炎治疗。从每项研究中提取有关研究人群以及可能影响病毒清除的因素的信息。病毒清除定义为急性丙型肝炎后至少随访6个月的个体。将病毒清除的受试者数量表示为每项研究的比例,并计算比例的加权平均值。共审查了31项研究。研究人群包括9项输血后肝炎研究、19项急性临床肝炎研究和3项血清感染病例研究。总共获得了675名受试者的数据,平均研究人群为22人(范围4 - 67人)。病毒清除的比例范围为0.0至0.8,加权平均值为0.26(95%置信区间0.22 - 0.29)。与病毒清除相关的因素为女性性别和急性临床丙型肝炎研究人群。需要进一步研究以更明确地确定清除的预测因素并指导治疗干预策略。

相似文献

1
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.急性丙型肝炎感染后的自发病毒清除:纵向研究的系统评价
J Viral Hepat. 2006 Jan;13(1):34-41. doi: 10.1111/j.1365-2893.2005.00651.x.
2
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.聚乙二醇化干扰素α-2a和α-2b联合利巴韦林治疗慢性丙型肝炎:系统评价与经济学评估
Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. doi: 10.3310/hta8390.
6
Population-based interventions for reducing sexually transmitted infections, including HIV infection.基于人群的减少性传播感染(包括艾滋病毒感染)的干预措施。
Cochrane Database Syst Rev. 2004(2):CD001220. doi: 10.1002/14651858.CD001220.pub2.
7
Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.成人慢性未抑制的HIV感染中的结构化治疗中断(STI)
Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD006148. doi: 10.1002/14651858.CD006148.
8
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
9
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
10
Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.丙型肝炎病毒相关混合性冷球蛋白血症的治疗
Cochrane Database Syst Rev. 2018 May 7;5(5):CD011403. doi: 10.1002/14651858.CD011403.pub2.

引用本文的文献

1
Temporal dynamics of viral fitness and the adaptive immune response in HCV infection.丙型肝炎病毒感染中病毒适应性和适应性免疫反应的时间动态变化
Elife. 2025 Aug 29;13:RP102232. doi: 10.7554/eLife.102232.
2
High false hepatitis C antibody positivity rate in a regionally-inclusive population of non-renumerated blood donors in Uganda.乌干达无偿献血者区域代表性人群中丙型肝炎抗体假阳性率较高。
Afr Health Sci. 2024 Sep;24(3):41-46. doi: 10.4314/ahs.v24i3.6.
3
Detection of anti-HCV antibodies in the clinical classification and epidemiological surveillance of HCV infection.
丙型肝炎病毒(HCV)感染临床分类及流行病学监测中抗-HCV抗体的检测
Mol Biol Rep. 2025 Jul 17;52(1):730. doi: 10.1007/s11033-025-10827-2.
4
Identity by descent and local ancestry mapping of HCV spontaneous clearance in populations of diverse ancestries.不同血统人群中丙型肝炎病毒自发清除的同源性和本地祖先图谱分析
BMC Genomics. 2025 Jul 12;26(1):661. doi: 10.1186/s12864-024-11076-6.
5
Update on the global burden of acute viral hepatitis in 2021: addressing health inequalities.2021年全球急性病毒性肝炎负担最新情况:应对健康不平等问题
Front Public Health. 2025 May 23;13:1580863. doi: 10.3389/fpubh.2025.1580863. eCollection 2025.
6
Cryo-EM structures of HCV E2 glycoprotein bound to neutralizing and non-neutralizing antibodies determined using bivalent Fabs as fiducial markers.利用二价Fab片段作为基准标记物测定的丙型肝炎病毒E2糖蛋白与中和及非中和抗体结合的冷冻电镜结构。
Commun Biol. 2025 May 29;8(1):825. doi: 10.1038/s42003-025-08239-w.
7
Estimated number of people infected with hepatitis B and C virus in Germany in 2013: a baseline prevalence estimate using the workbook method.2013年德国感染乙型和丙型肝炎病毒的估计人数:使用工作簿法的基线患病率估计值。
Front Public Health. 2025 Apr 7;13:1471256. doi: 10.3389/fpubh.2025.1471256. eCollection 2025.
8
Prevalence and Risk Factors of Occult HCV Infection in the Adult Population of Mexico City.墨西哥城成年人群中隐匿性丙型肝炎病毒感染的患病率及危险因素
Viruses. 2025 Feb 8;17(2):236. doi: 10.3390/v17020236.
9
Building a Low-Threshold Model for HCV Diagnosis and Treatment Among Formerly Incarcerated Patients in Alabama.为阿拉巴马州曾经入狱的患者建立丙型肝炎病毒诊断与治疗的低门槛模型。
J Gen Intern Med. 2025 Feb 12. doi: 10.1007/s11606-025-09411-y.
10
Notification of blood donors who test positive for transfusion-transmissible infections.对输血传播感染检测呈阳性的献血者的通知。
Vox Sang. 2025 Apr;120(4):394-400. doi: 10.1111/vox.13796. Epub 2025 Jan 14.